Showing results (61-70 of 225) with videos related to
Sort By:
Pageof 23
Frontiers in Cellular and Infection Microbiology|February 10, 2017
Oral Multiple Sclerosis Drugs Inhibit the In vitro Growth of Epsilon Toxin Producing Gut Bacterium, Clostridium perfringensKareem R Rumah, Timothy K Vartanian, Vincent A FischettiInternational Journal of Food Microbiology|January 26, 2021
Decontamination of Escherichia coli O157:H7 on fresh Romaine lettuce using a novel bacteriophage lysinSiyue Xu, Edmondo Campisi, Jinquan Li, et al.Frontiers in Microbiology|April 4, 2022
PaP1, a Broad-Spectrum Lysin-Derived Cationic Peptide to Treat Polymicrobial Skin InfectionsRyan D Heselpoth, Chad W Euler, Vincent A FischettiAntimicrobial Agents and Chemotherapy|November 12, 2025
Second-generation lysocins as therapeutics for treating Pseudomonas aeruginosa infectionsRyan D Heselpoth, Chad W Euler, Vincent A FischettiFEMS Immunology and Medical Microbiology|November 8, 2006
Lack of in vitro biofilm formation does not attenuate the virulence of Streptococcus gordonii in experimental endocarditisAlain Bizzini, Siham Beggah-Möller, Philippe Moreillon, et al.Antimicrobial Agents and Chemotherapy|March 14, 2007
Single-dose oral amoxicillin or linezolid for prophylaxis of experimental endocarditis due to vancomycin-susceptible and vancomycin-resistant Enterococcus faecalisPhilippe Moreillon, Walter R Wilson, Roland Leclercq, et al.BMC Microbiology|October 15, 2005
Genometrics as an essential tool for the assembly of whole genome sequences: the example of the chromosome of Bifidobacterium longum NCC2705Lionel Guy, Dimitri Karamata, Philippe Moreillon, et al.Current Infectious Disease Reports|July 11, 2006
New concepts in the pathophysiology of infective endocarditisEleonora Widmer, Yok-Ai Que, José M Entenza, et al.Journal of Proteomics|December 31, 2011
Evidence for a new post-translational modification in Staphylococcus aureus: hydroxymethylation of asparagine and glutaminePatrice Waridel, Mathilde Ythier, Aurélie Gfeller, et al.Antimicrobial Agents and Chemotherapy|December 25, 2003
Efficacy of garenoxacin in treatment of experimental endocarditis due to Staphylococcus aureus or viridans group streptococciJosé M Entenza, Jacques Vouillamoz, Michel P Glauser, et al.Pageof 23